hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152 USA. NDC # 0904-6440-61
Published March 23, 2022 · Recall initiated: February 24, 2022
Summary
FDA records drug Class II recall D-0653-2022, published March 23, 2022 and initiated February 24, 2022. Recalling firm: The Harvard Drug Group; Status: Terminated; Reported quantity: 5,953 cartons; Lot: Lot #: T03755, T03756, Exp. Date 03/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Out of specification result obtained during routine stability testing for Impurities.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- The Harvard Drug Group
- Distributor
- Nationwide within USA
- Lot
- Lot #: T03755, T03756, Exp. Date 03/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATramadol Hydrochloride Tablets, USP 50 mg, Unit Dose 100-Count Tablets Rx only, Manufactured by: SunJuly 5, 2023
- FDAGabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), RxMay 17, 2023
- FDACarbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in CzechMarch 8, 2023
- FDAAlprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY;March 23, 2022
- FDAPALIPERIDONE EXTENDED-RELEASE TABLETS, 9 mg, 100 Tablets per carton (10 x 10 blister packs), Rx only,March 16, 2022
- FDAHeartSine Samaritan PAD, SAM 350P Semi-Automatic Defibrillator, used with Pad-PakMarch 16, 2022
Questions about this recall
Was hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152 USA. NDC # 0904-6440-61 recalled?
Yes. FDA published recall D-0653-2022 on March 23, 2022. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification result obtained during routine stability testing for Impurities.
What should I do if I have this product?
Voluntary: Firm initiated · Letter